Cyclo Therapeutics, Inc.·4

Mar 9, 5:10 PM ET

Fine Joshua M 4

4 · Cyclo Therapeutics, Inc. · Filed Mar 9, 2023

Insider Transaction Report

Form 4
Period: 2023-03-07
Fine Joshua M
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2023-03-07+41,03641,036 total
    Exercise: $1.28Exp: 2033-03-07Common Stock (41,036 underlying)
Footnotes (1)
  • [F1]The option vests over a four year period in equal monthly installments.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4